Is AZN up or down today?
AZN is down 1.64% today, last at 160.04. This stock moved -1.64% versus the prior close.
AZN · AZN
AZN (AZN) is trading at 160.04, down 1.64% on the session. AZN sits at the 7% mark of its 52-week range, carries a 14-day RSI of 42, and trades below its 50-day average. Over the past month it is down 0.85%.
Leading the coverage: “AstraZeneca Wins FDA Accelerated Approval for Breast Cancer Drug Etcamah” (Yahoo, 4d ago). AZN is -1.27% since story.
AZN trades on a trailing P/E of 27.4 and is running 0.09% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
AZN is down 1.64% today, last at 160.04. This stock moved -1.64% versus the prior close.
Leading the coverage: “AstraZeneca Wins FDA Accelerated Approval for Breast Cancer Drug Etcamah” (Yahoo, 4d ago). AZN is -1.27% since story. Dominant story: Amgen, AstraZeneca combination improves survival measures in late-stage lung cancer study (1 source, neutral) RSI is 42 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (124 days) · Drag or scroll left for earlier dates
Amgen, AstraZeneca combination improves survival measures in late-stage lung cancer study
AstraZeneca (LSE:AZN) Posts Phase III Survival Win In Small Cell Lung Cancer - simplywall.st
AstraZeneca PLC (AZN) Presents at European Respiratory Society (ERS) Congress - Slideshow - Seeking Alpha
AstraZeneca PLC (AZN) Presents at European Respiratory Society (ERS) Congress Transcript
AZN Looks 10.1% Undervalued on GF Value™ as Dividend Remains Att - GuruFocus